Tyra Biosciences Prices $400 Million Stock Offering for Growth of Precision Medicines #USA #Carlsbad #Tyra_Biosciences #FGFR_Biology #Dabogratinib
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialTyra Biosciences Unveils Promising Phase 2 Results for Oral Dabogratinib in Treating Low-Grade NMIBC #USA #Carlsbad #Tyra_Biosciences #NMIBC #Dabogratinib